Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 159 entries
Sorted by: Best Match Show Resources per page
[Measles in children immunized with live measles vaccine].

Voprosy okhrany materinstva i detstva

Bystriakova LV, Oblapenko GP, Smorodinova IP.
PMID: 5532747
Vopr Okhr Materin Det. 1970 Nov;15(11):37-40.

No abstract available.

Cite
Bystriakova LV, Oblapenko GP, Smorodinova IP. Kor' u deteĭ, privitykh zhivoĭ korevoĭ vaktsinoĭ. [Measles in children immunized with live measles vaccine]. Vopr Okhr Materin Det. 1970;15(11):37-40
Bystriakova, L. V., Oblapenko, G. P., & Smorodinova, I. P. (1970). Kor' u deteĭ, privitykh zhivoĭ korevoĭ vaktsinoĭ. [Measles in children immunized with live measles vaccine]. Voprosy okhrany materinstva i detstva, 15(11), 37-40.
Bystriakova, L V, et al. "Kor' u deteĭ, privitykh zhivoĭ korevoĭ vaktsinoĭ." [Measles in children immunized with live measles vaccine]. Voprosy okhrany materinstva i detstva vol. 15,11 (1970): 37-40.
Bystriakova LV, Oblapenko GP, Smorodinova IP. Kor' u deteĭ, privitykh zhivoĭ korevoĭ vaktsinoĭ. [Measles in children immunized with live measles vaccine]. Vopr Okhr Materin Det. 1970 Nov;15(11):37-40. Russian. PMID: 5532747.
Copy Download .nbib Format: NLM
Cost-effectiveness analysis of routine immunization and supplementary immunization activity for measles in a health district of Benin.

Cost effectiveness and resource allocation : C/E

Kaucley L, Levy P.
PMID: 26300696
Cost Eff Resour Alloc. 2015 Aug 20;13:14. doi: 10.1186/s12962-015-0039-7. eCollection 2015.

BACKGROUND: This study was carried out at district level to describe the cost structure and measure the effectiveness of delivering supplementary immunization activity (SIA) and routine immunization (RI) for measles in Benin, a country heavily affected by this disease.METHODS:...

Cite
Kaucley L, Levy P. Cost-effectiveness analysis of routine immunization and supplementary immunization activity for measles in a health district of Benin. Cost Eff Resour Alloc. 2015;13:14doi: 10.1186/s12962-015-0039-7.
Kaucley, L., & Levy, P. (2015). Cost-effectiveness analysis of routine immunization and supplementary immunization activity for measles in a health district of Benin. Cost effectiveness and resource allocation : C/E, 1314. https://doi.org/10.1186/s12962-015-0039-7
Kaucley, Landry, and Levy, Pierre. "Cost-effectiveness analysis of routine immunization and supplementary immunization activity for measles in a health district of Benin." Cost effectiveness and resource allocation : C/E vol. 13 (2015): 14. doi: https://doi.org/10.1186/s12962-015-0039-7
Kaucley L, Levy P. Cost-effectiveness analysis of routine immunization and supplementary immunization activity for measles in a health district of Benin. Cost Eff Resour Alloc. 2015 Aug 20;13:14. doi: 10.1186/s12962-015-0039-7. eCollection 2015. PMID: 26300696; PMCID: PMC4545866.
Copy Download .nbib Format: NLM
Detection by polymerase chain reaction of wild-type measles virus genome in the cerebrospinal fluid of a patient with SSPE who had received measles vaccine.

Clinical and diagnostic virology

Suga S, Miyahara M, Obata M, Higashigawa M, Ito M, Ihara T, Kamiya H, Sheng J, Ueda S, Sakurai M.
PMID: 15566859
Clin Diagn Virol. 1996 Feb;5(1):37-42. doi: 10.1016/0928-0197(95)00157-3.

BACKGROUND: Previous studies have reported that approximately 4-5% of patients with subacute sclerosing panencephalitis (SSPE) were given measles vaccination but had no history of natural measles. However, in the case who received measles vaccine, it has been extremely difficult...

Cite
Suga S, Miyahara M, Obata M, et al. Detection by polymerase chain reaction of wild-type measles virus genome in the cerebrospinal fluid of a patient with SSPE who had received measles vaccine. Clin Diagn Virol. 1996;5(1):37-42doi: 10.1016/0928-0197(95)00157-3.
Suga, S., Miyahara, M., Obata, M., Higashigawa, M., Ito, M., Ihara, T., Kamiya, H., Sheng, J., Ueda, S., & Sakurai, M. (1996). Detection by polymerase chain reaction of wild-type measles virus genome in the cerebrospinal fluid of a patient with SSPE who had received measles vaccine. Clinical and diagnostic virology, 5(1), 37-42. https://doi.org/10.1016/0928-0197(95)00157-3
Suga, S, et al. "Detection by polymerase chain reaction of wild-type measles virus genome in the cerebrospinal fluid of a patient with SSPE who had received measles vaccine." Clinical and diagnostic virology vol. 5,1 (1996): 37-42. doi: https://doi.org/10.1016/0928-0197(95)00157-3
Suga S, Miyahara M, Obata M, Higashigawa M, Ito M, Ihara T, Kamiya H, Sheng J, Ueda S, Sakurai M. Detection by polymerase chain reaction of wild-type measles virus genome in the cerebrospinal fluid of a patient with SSPE who had received measles vaccine. Clin Diagn Virol. 1996 Feb;5(1):37-42. doi: 10.1016/0928-0197(95)00157-3. PMID: 15566859.
Copy Download .nbib Format: NLM
Measles vaccines.

Canadian Medical Association journal

Bishop J.
PMID: 20328774
Can Med Assoc J. 1967 Mar 18;96(11):681.

No abstract available.

Cite
Bishop J. Measles vaccines. Can Med Assoc J. 1967;96(11):681
Bishop, J. (1967). Measles vaccines. Canadian Medical Association journal, 96(11), 681.
Bishop, J. "Measles vaccines." Canadian Medical Association journal vol. 96,11 (1967): 681.
Bishop J. Measles vaccines. Can Med Assoc J. 1967 Mar 18;96(11):681. PMID: 20328774; PMCID: PMC1936061.
Copy Download .nbib Format: NLM
Following in the footsteps of smallpox: can we achieve the global eradication of measles?.

BMC international health and human rights

Morgan OW.
PMID: 15102333
BMC Int Health Hum Rights. 2004 Mar 17;4(1):1. doi: 10.1186/1472-698X-4-1.

BACKGROUND: Although an effective measles vaccine has been available for almost 40 years, in 2000 there were about 30 million measles infections worldwide and 777,000 measles-related deaths. The history of smallpox suggests that achieving measles eradication depends on several...

Cite
Morgan OW. Following in the footsteps of smallpox: can we achieve the global eradication of measles?. BMC Int Health Hum Rights. 2004;4(1):1doi: 10.1186/1472-698X-4-1.
Morgan, O. W. (2004). Following in the footsteps of smallpox: can we achieve the global eradication of measles?. BMC international health and human rights, 4(1), 1. https://doi.org/10.1186/1472-698X-4-1
Morgan, Oliver WC. "Following in the footsteps of smallpox: can we achieve the global eradication of measles?." BMC international health and human rights vol. 4,1 (2004): 1. doi: https://doi.org/10.1186/1472-698X-4-1
Morgan OW. Following in the footsteps of smallpox: can we achieve the global eradication of measles?. BMC Int Health Hum Rights. 2004 Mar 17;4(1):1. doi: 10.1186/1472-698X-4-1. PMID: 15102333; PMCID: PMC387835.
Copy Download .nbib Format: NLM
Measles virus hemagglutinin: structural insights into cell entry and measles vaccine.

Frontiers in microbiology

Hashiguchi T, Maenaka K, Yanagi Y.
PMID: 22319511
Front Microbiol. 2011 Dec 16;2:247. doi: 10.3389/fmicb.2011.00247. eCollection 2011.

Measles is one of the most contagious viral diseases, and remains a major cause of childhood morbidity and mortality worldwide. The measles virus (MV), a member of the family Paramyxoviridae, enters cells through a cellular receptor, the signaling lymphocyte...

Cite
Hashiguchi T, Maenaka K, Yanagi Y. Measles virus hemagglutinin: structural insights into cell entry and measles vaccine. Front Microbiol. 2011;2:247doi: 10.3389/fmicb.2011.00247.
Hashiguchi, T., Maenaka, K., & Yanagi, Y. (2011). Measles virus hemagglutinin: structural insights into cell entry and measles vaccine. Frontiers in microbiology, 2247. https://doi.org/10.3389/fmicb.2011.00247
Hashiguchi, Takao, et al. "Measles virus hemagglutinin: structural insights into cell entry and measles vaccine." Frontiers in microbiology vol. 2 (2011): 247. doi: https://doi.org/10.3389/fmicb.2011.00247
Hashiguchi T, Maenaka K, Yanagi Y. Measles virus hemagglutinin: structural insights into cell entry and measles vaccine. Front Microbiol. 2011 Dec 16;2:247. doi: 10.3389/fmicb.2011.00247. eCollection 2011. PMID: 22319511; PMCID: PMC3267179.
Copy Download .nbib Format: NLM
The optimal age of measles immunisation in low-income countries: a secondary analysis of the assumptions underlying the current policy.

BMJ open

Aaby P, Martins CL, Garly ML, Rodrigues A, Benn CS, Whittle H.
PMID: 22815465
BMJ Open. 2012 Jul 19;2(4). doi: 10.1136/bmjopen-2011-000761. Print 2012.

OBJECTIVE: The current policy of measles vaccination at 9 months of age was decided in the mid-1970s. The policy was not tested for impact on child survival but was based on studies of seroconversion after measles vaccination at different...

Cite
Aaby P, Martins CL, Garly ML, et al. The optimal age of measles immunisation in low-income countries: a secondary analysis of the assumptions underlying the current policy. BMJ Open. 2012;2(4)doi: 10.1136/bmjopen-2011-000761.
Aaby, P., Martins, C. L., Garly, M. L., Rodrigues, A., Benn, C. S., & Whittle, H. (2012). The optimal age of measles immunisation in low-income countries: a secondary analysis of the assumptions underlying the current policy. BMJ open, 2(4), . https://doi.org/10.1136/bmjopen-2011-000761
Aaby, Peter, et al. "The optimal age of measles immunisation in low-income countries: a secondary analysis of the assumptions underlying the current policy." BMJ open vol. 2,4 (2012). doi: https://doi.org/10.1136/bmjopen-2011-000761
Aaby P, Martins CL, Garly ML, Rodrigues A, Benn CS, Whittle H. The optimal age of measles immunisation in low-income countries: a secondary analysis of the assumptions underlying the current policy. BMJ Open. 2012 Jul 19;2(4). doi: 10.1136/bmjopen-2011-000761. Print 2012. PMID: 22815465; PMCID: PMC3401826.
Copy Download .nbib Format: NLM
Coverage, Timelines, and Determinants of Incomplete Immunization in Bangladesh.

Tropical medicine and infectious disease

Sheikh N, Sultana M, Ali N, Akram R, Mahumud RA, Asaduzzaman M, Sarker AR.
PMID: 30274468
Trop Med Infect Dis. 2018 Jun 25;3(3). doi: 10.3390/tropicalmed3030072.

Immunization has become one of the major contributors to public health globally as it prevents communicable disease, particularly in children. The objective of this study was to estimate the extent of timely immunization coverage and to investigate the determinants...

Cite
Sheikh N, Sultana M, Ali N, et al. Coverage, Timelines, and Determinants of Incomplete Immunization in Bangladesh. Trop Med Infect Dis. 2018;3(3)doi: 10.3390/tropicalmed3030072.
Sheikh, N., Sultana, M., Ali, N., Akram, R., Mahumud, R. A., Asaduzzaman, M., & Sarker, A. R. (2018). Coverage, Timelines, and Determinants of Incomplete Immunization in Bangladesh. Tropical medicine and infectious disease, 3(3), . https://doi.org/10.3390/tropicalmed3030072
Sheikh, Nurnabi, et al. "Coverage, Timelines, and Determinants of Incomplete Immunization in Bangladesh." Tropical medicine and infectious disease vol. 3,3 (2018). doi: https://doi.org/10.3390/tropicalmed3030072
Sheikh N, Sultana M, Ali N, Akram R, Mahumud RA, Asaduzzaman M, Sarker AR. Coverage, Timelines, and Determinants of Incomplete Immunization in Bangladesh. Trop Med Infect Dis. 2018 Jun 25;3(3). doi: 10.3390/tropicalmed3030072. PMID: 30274468; PMCID: PMC6160906.
Copy Download .nbib Format: NLM
Recombinant measles vaccine expressing malaria antigens induces long-term memory and protection in mice.

NPJ vaccines

Mura M, Ruffié C, Combredet C, Aliprandini E, Formaglio P, Chitnis CE, Amino R, Tangy F.
PMID: 30820355
NPJ Vaccines. 2019 Feb 27;4:12. doi: 10.1038/s41541-019-0106-8. eCollection 2019.

Following the RTS,S malaria vaccine, which showed only partial protection with short-term memory, there is strong support to develop second-generation malaria vaccines that yield higher efficacy with longer duration. The use of replicating viral vectors to deliver subunit vaccines...

Cite
Mura M, Ruffié C, Combredet C, et al. Recombinant measles vaccine expressing malaria antigens induces long-term memory and protection in mice. NPJ Vaccines. 2019;4:12doi: 10.1038/s41541-019-0106-8.
Mura, M., Ruffié, C., Combredet, C., Aliprandini, E., Formaglio, P., Chitnis, C. E., Amino, R., & Tangy, F. (2019). Recombinant measles vaccine expressing malaria antigens induces long-term memory and protection in mice. NPJ vaccines, 412. https://doi.org/10.1038/s41541-019-0106-8
Mura, Marie, et al. "Recombinant measles vaccine expressing malaria antigens induces long-term memory and protection in mice." NPJ vaccines vol. 4 (2019): 12. doi: https://doi.org/10.1038/s41541-019-0106-8
Mura M, Ruffié C, Combredet C, Aliprandini E, Formaglio P, Chitnis CE, Amino R, Tangy F. Recombinant measles vaccine expressing malaria antigens induces long-term memory and protection in mice. NPJ Vaccines. 2019 Feb 27;4:12. doi: 10.1038/s41541-019-0106-8. eCollection 2019. PMID: 30820355; PMCID: PMC6393439.
Copy Download .nbib Format: NLM
Preference in the use of full childhood immunizations in Ethiopia: the role of maternal health services.

Patient preference and adherence

Regassa N, Bird Y, Moraros J.
PMID: 30662259
Patient Prefer Adherence. 2019 Jan 08;13:91-99. doi: 10.2147/PPA.S189844. eCollection 2019.

BACKGROUND: Immunizations represent a successful and cost-effective public health strategy in preventing common childhood diseases. Ethiopia has made remarkable progress in increasing its full immunization coverage, but significant gaps remain. This study aims to measure the preference in the...

Cite
Regassa N, Bird Y, Moraros J. Preference in the use of full childhood immunizations in Ethiopia: the role of maternal health services. Patient Prefer Adherence. 2019;13:91-99doi: 10.2147/PPA.S189844.
Regassa, N., Bird, Y., & Moraros, J. (2019). Preference in the use of full childhood immunizations in Ethiopia: the role of maternal health services. Patient preference and adherence, 1391-99. https://doi.org/10.2147/PPA.S189844
Regassa, Nigatu, et al. "Preference in the use of full childhood immunizations in Ethiopia: the role of maternal health services." Patient preference and adherence vol. 13 (2019): 91-99. doi: https://doi.org/10.2147/PPA.S189844
Regassa N, Bird Y, Moraros J. Preference in the use of full childhood immunizations in Ethiopia: the role of maternal health services. Patient Prefer Adherence. 2019 Jan 08;13:91-99. doi: 10.2147/PPA.S189844. eCollection 2019. PMID: 30662259; PMCID: PMC6329350.
Copy Download .nbib Format: NLM
National Immunization Campaigns with Oral Polio Vaccine Reduce All-Cause Mortality: A Natural Experiment within Seven Randomized Trials.

Frontiers in public health

Andersen A, Fisker AB, Rodrigues A, Martins C, Ravn H, Lund N, Biering-Sørensen S, Benn CS, Aaby P.
PMID: 29456992
Front Public Health. 2018 Feb 02;6:13. doi: 10.3389/fpubh.2018.00013. eCollection 2018.

BACKGROUND: A recent WHO review concluded that live BCG and measles vaccine (MV) may have beneficial non-specific effects (NSEs) reducing mortality from non-targeted diseases. NSEs of oral polio vaccine (OPV) were not examined. If OPV vaccination campaigns reduce the...

Cite
Andersen A, Fisker AB, Rodrigues A, et al. National Immunization Campaigns with Oral Polio Vaccine Reduce All-Cause Mortality: A Natural Experiment within Seven Randomized Trials. Front Public Health. 2018;6:13doi: 10.3389/fpubh.2018.00013.
Andersen, A., Fisker, A. B., Rodrigues, A., Martins, C., Ravn, H., Lund, N., Biering-Sørensen, S., Benn, C. S., & Aaby, P. (2018). National Immunization Campaigns with Oral Polio Vaccine Reduce All-Cause Mortality: A Natural Experiment within Seven Randomized Trials. Frontiers in public health, 613. https://doi.org/10.3389/fpubh.2018.00013
Andersen, Andreas, et al. "National Immunization Campaigns with Oral Polio Vaccine Reduce All-Cause Mortality: A Natural Experiment within Seven Randomized Trials." Frontiers in public health vol. 6 (2018): 13. doi: https://doi.org/10.3389/fpubh.2018.00013
Andersen A, Fisker AB, Rodrigues A, Martins C, Ravn H, Lund N, Biering-Sørensen S, Benn CS, Aaby P. National Immunization Campaigns with Oral Polio Vaccine Reduce All-Cause Mortality: A Natural Experiment within Seven Randomized Trials. Front Public Health. 2018 Feb 02;6:13. doi: 10.3389/fpubh.2018.00013. eCollection 2018. PMID: 29456992; PMCID: PMC5801299.
Copy Download .nbib Format: NLM
Modified Measles in an Anti-Measles Immunoglobulin G-negative Healthcare Worker who had Received Two Doses of Measles-Containing Vaccine.

Infection & chemotherapy

Park JW, Yu SN, Park E, Lee Y, Park SM, Jeon MH.
PMID: 31583864
Infect Chemother. 2019 Sep;51(3):305-309. doi: 10.3947/ic.2019.51.3.305.

To date, documentation of two doses of measles-containing vaccine (MCV) has been accepted as confirmation of measles immunity among healthcare workers (HCWs). However, we encountered measles in an HCW who had received two doses of MCV. A patient with...

Cite
Park JW, Yu SN, Park E, et al. Modified Measles in an Anti-Measles Immunoglobulin G-negative Healthcare Worker who had Received Two Doses of Measles-Containing Vaccine. Infect Chemother. 2019;51(3):305-309doi: 10.3947/ic.2019.51.3.305.
Park, J. W., Yu, S. N., Park, E., Lee, Y., Park, S. M., & Jeon, M. H. (2019). Modified Measles in an Anti-Measles Immunoglobulin G-negative Healthcare Worker who had Received Two Doses of Measles-Containing Vaccine. Infection & chemotherapy, 51(3), 305-309. https://doi.org/10.3947/ic.2019.51.3.305
Park, Jung Wan, et al. "Modified Measles in an Anti-Measles Immunoglobulin G-negative Healthcare Worker who had Received Two Doses of Measles-Containing Vaccine." Infection & chemotherapy vol. 51,3 (2019): 305-309. doi: https://doi.org/10.3947/ic.2019.51.3.305
Park JW, Yu SN, Park E, Lee Y, Park SM, Jeon MH. Modified Measles in an Anti-Measles Immunoglobulin G-negative Healthcare Worker who had Received Two Doses of Measles-Containing Vaccine. Infect Chemother. 2019 Sep;51(3):305-309. doi: 10.3947/ic.2019.51.3.305. PMID: 31583864; PMCID: PMC6779578.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 159 entries